← Back to headlines
FDA Fast-Tracks Breakthrough Oral Drug for Pancreatic Cancer That Doubles Survival Rates
The US Food and Drug Administration has granted accelerated approval to a new tablet therapy capable of extending life by up to two times for patients with advanced pancreatic cancer.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.



